Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Resolution of malignant cutaneous lesions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma Advani, R., Pro, B., Kennedy, D., Fanale, M. MOSBY-ELSEVIER. 2012: AB4
View details for Web of Science ID 000302319800016